Raymond James & Associates’s Aptinyx Inc. Common Stock APTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-26,675
Closed -$3.33K 4029
2023
Q1
$3.33K Sell
26,675
-19,400
-42% -$7.07K ﹤0.01% 3862
2022
Q4
$13.1K Sell
46,075
-27,950
-38% -$8.07K ﹤0.01% 3831
2022
Q3
$27K Hold
74,025
﹤0.01% 3770
2022
Q2
$41K Sell
74,025
-16,835
-19% -$13.5K ﹤0.01% 3811
2022
Q1
$206K Buy
90,860
+480
+0.5% +$1.44K ﹤0.01% 3656
2021
Q4
$241K Sell
90,380
-22,950
-20% -$55.2K ﹤0.01% 3581
2021
Q3
$265K Sell
113,330
-14,400
-11% -$36.7K ﹤0.01% 3504
2021
Q2
$361K Sell
127,730
-18,055
-12% -$50.4K ﹤0.01% 3306
2021
Q1
$437K Sell
145,785
-43,685
-23% -$157K ﹤0.01% 3123
2020
Q4
$656K Buy
189,470
+142,650
+305% +$497K ﹤0.01% 2630
2020
Q3
$158K Buy
46,820
+26,120
+126% +$100K ﹤0.01% 3291
2020
Q2
$86K Buy
+20,700
New +$70.1K ﹤0.01% 3317

Other funds holding APTX

Raymond James & Associates's APTX Position: Q2 2023 in Review

Raymond James & Associates sold out of Aptinyx Inc. Common Stock (APTX) in Q2 2023, closing a stake of 26,675 shares — an estimated $3.33K sold.

Raymond James & Associates first reported a position in APTX in Q2 2020 and held it in 12 quarters. The position peaked at $656K in Q4 2020. 3 funds tracked by Wall St. Rank hold APTX as of Q2 2023.

  • Raymond James & Associates reported no remaining Aptinyx Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 26,675 Aptinyx Inc. Common Stock shares in Q2 2023, an estimated $3.33K.
  • Raymond James & Associates first reported a position in Aptinyx Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Raymond James & Associates's Aptinyx Inc. Common Stock position peaked at $656K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.